The clinical value of concomitant Epstein Barr virus (EBV)-DNA load and specific immune reconstitution monitoring after allogeneic hematopoietic stem cell transplantation. (Q45367896)

From Wikidata

Jump to navigation Jump to search

scientific article published on 2 April 2011

Language	Label	Description	Also known as
English	The clinical value of concomitant Epstein Barr virus (EBV)-DNA load and specific immune reconstitution monitoring after allogeneic hematopoietic stem cell transplantation.	scientific article published on 2 April 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440066%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

The clinical value of concomitant Epstein Barr virus (EBV)-DNA load and specific immune reconstitution monitoring after allogeneic hematopoietic stem cell transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440066%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Jean-Marc Virion

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440066%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Maud D'Aveni

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440066%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Lamia Aïssi-Rothé

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440066%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Véronique Venard

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440066%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Alexandra Salmon

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440066%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Aude Falenga

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440066%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Véronique Decot

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440066%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Yingying Wang

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440066%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Laurence Clement

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440066%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Véronique Latger-Cannard

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440066%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Cécile Tomowiak

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440066%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Jean François Stoltz

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440066%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Pierre Bordigoni

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440066%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Danièle Bensoussan

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440066%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

2 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440066%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Transplant Immunology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440066%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440066%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440066%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

224-232

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440066%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

A prospective study of Epstein-Barr virus load in 85 hematopoietic stem cell transplants

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

Epstein-Barr Viral Load and Disease Prediction in a Large Cohort of Allogeneic Stem Cell Transplant Recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

Retrospective evaluation of serum Epstein Barr virus DNA levels in 406 allogeneic stem cell transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

Prompt versus preemptive intervention for EBV lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

Epstein-Barr viral load as a tool to diagnose and monitor post-transplant lymphoproliferative disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

Impaired recovery of Epstein-Barr virus (EBV)--specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

Prevention of EBV-induced B-lymphoproliferative disorder by ex vivo marrow B-cell depletion in HLA-phenoidentical or non-identical T-depleted bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

EBV specific CTL: a model for immune therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

Management of Epstein-Barr virus (EBV) reactivation after allogeneic stem cell transplantation by simultaneous analysis of EBV DNA load and EBV-specific T cell reconstitution.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

Adoptive immunotherapy for EBV-associated malignancies

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

Improvement of cellular immunity and IgA production in immunodeficient children after treatment with synthetic serum thymic factor (FTS)

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

Rapid generation of full clinical-grade human antiadenovirus cytotoxic T cells for adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

Definition of an immunologic response using the major histocompatibility complex tetramer and enzyme-linked immunospot assays

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

Tetramer-assisted identification and characterization of epitopes recognized by HLA A*2402-restricted Epstein-Barr virus-specific CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

Quantitation, selection, and functional characterization of Epstein-Barr virus-specific and alloreactive T cells detected by intracellular interferon-gamma production and growth of cytotoxic precursors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

Prediction of T-cell reconstitution by assessment of T-cell receptor excision circle before allogeneic hematopoietic stem cell transplantation in pediatric patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

T cells and viral persistence: lessons from diverse infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

Cellular immune parameters associated with spontaneous control of CMV in children who underwent transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

Quantitative and qualitative CD4 T cell immune responses related to adenovirus DNAemia in hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

Delay in B-lymphocyte recovery and function following rituximab for EBV-associated lymphoproliferative disease early post-allogeneic hematopoietic SCT.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2011.03.002

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.TRIM.2011.03.002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440066%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21440066%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45367896&oldid=1381929058"